Market cap: $19,175,595
Exchange: NAS
Sector: Health Technology
Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.
Company Name
Aptose Biosciences Inc
Average Volume (10 days)
41,493
Average Volume (30 days)
76,695
Moving Average (50 days)
$1.44
Moving Average (200 days)
$2.12
Ex-Divided Date
n/a
Dividend Yield
0
P/E Ratio
0
Market Cap
19,175,595
Shares Outstanding
15,717,701
52-Week High Split Adjust Only
8.7
52-Week Low Split Adjust Only
1.2
Employee Count
54
Beta
0.2997
Next Earnings Date
2024-05-08
TTM Dividend Rate Per Share
0
Past 5 days
-0.03%
Past 30 days
-0.21%
Past 3 months
-0.42%
Past 6 months
-0.53%
Past year
-0.83%
Past 2 years
-0.93%
Past 5 years
-0.96%
Max % Change
4.55%
| Name | Ticker | Price/Sales (ttm) | Price/Book (ttm) | Forward P/E | PEG Ratio | EV/Revenue |
|---|---|---|---|---|---|---|
| Aptose Biosciences Inc | APTO | n/a | n/a | -7.4 | n/a | n/a |
| Peer Avg | N/A | 35.66 | -0.07 | -7.3 | 35.66 | 21.57 |
| Corbus Pharmaceuticals Holdings Inc | CRBP | 96.11 | 2.96 | -3.0 | 96.11 | 58.77 |
| Agenus Inc | AGEN | 11.18 | -5.00 | -4.1 | 11.18 | 10.01 |
| Affimed N.V. | AFMD | n/a | n/a | -19.3 | n/a | n/a |
| Advaxis, Inc. | ADXS | 35.36 | 1.76 | -2.8 | 35.36 | 17.49 |